Efoksa - instruction , application reviews


1. Indications and contraindications for Efoksa

2. Instructions for use Efoksa

3. Side effects Efoksa

4. Overdose Efoksa

5. Analogs Efoksa

6. Cautions

Efoksa - a drug that belongs to the group of antianginal agents and peripheral vasodilators.

Efoksa is an organic nitrate, acting mainly on the venous vessels.In addition, it is able to reduce the preload and afterload on the myocardium, reducing its need for oxygen.The use of this tool can reduce blood flow to the right atrium, resulting in a reduction of pressure in the pulmonary circulation.In addition, Efoksa has a beneficial effect on the distribution of coronary blood flow in areas of the body with reduced circulation.

Antianginal effect of the drug occurs in about 40-45 minutes after application, and its duration is 9-10 hours.

Efoksa manufacturer produces a flat, round tablets white.Each package contains 10 of their pieces.

Indications and contraindications for Efoksa

According to the instructions t

o the tool Efoksa prescribed to prevent angina attacks in patients with coronary artery disease entities, as well as part of a combined treatment of chronic heart failure.

It should be noted that during the drug therapy in patients with angina and ischemic heart disease observed increase endurance during exercise.

As for contraindications to the drug, the Efoksa not applied in such diseases and conditions of the patient as:

  • acute circulatory disorders;
  • cardiogenic shock;
  • severe hypotension;
  • hypovolemia;
  • myocardial infarction in the acute form, which is accompanied by arterial hypotension;
  • anemia in severe;
  • toxic pulmonary edema;
  • age of 18 years;
  • hereditary galactose intolerance, glucose malabsorption syndrome and galactose, lactase deficiency;
  • hypersensitivity to the components of the composition Efoksa.

It should be noted that this drug is not allowed to take concurrently with phosphodiesterase inhibitors, as this could provoke a strong hypotensive effect.

Under certain conditions and diseases the drug is allowed to use under close medical supervision.Data states include:

  • constrictive pericarditis;
  • hypertrophic obstructive cardiomyopathy;
  • pericardial tamponade;
  • mitral or aortic stenosis;
  • patient's tendency to arterial hypotension;
  • myocardial infarction in the acute form;
  • glaucoma;
  • heart failure, which is accompanied by a low-pressure filling of the left ventricle;
  • diseases, which are accompanied by increased intracranial pressure, including hemorrhagic stroke, as well as recently transferred head trauma;
  • renal or hepatic impairment;
  • severe form of anemia.

Instructions for use Efoksa

According to the instructions Efoksa, tablets should be taken orally after a meal, drinking plenty of fluids.Duration of treatment and dosage of medication the doctor prescribes individually based on the patient's condition and features of course of his illness.

Receiving the drug should start with small doses: 10 mg 2 times a day.Gradually increase the dose, leading to therapeutic 20-40 mg 1-2 times a day, and in case of necessity it can be increased to 60 mg.

Side effects Efoksa

In applying the drug may experience the following side effects:

  • disorders of the central nervous system: headache, dizziness, orthostatic collapse, kollaptoidnye state, fainting, blurred vision, stiffness, drowsiness, decreased motor and mental speedreactions;
  • disorders of the cardiovascular system: tachycardia, facial flushing, heat sensation, decreased blood pressure, increased heart rate, increased angina;
  • disorders of the digestive system functions: nausea, vomiting, dry mouth, feeling light burning tongue;
  • allergic reactions: skin rash, dermatitis;
  • development of tolerance.

Overdose Efoksa

Application Efoksa or analogues at doses higher than recommended, can cause an overdose, the symptoms of which are:

  • palpitations;
  • weakness;
  • sweating;
  • decrease in blood pressure;
  • headache and dizziness;
  • retardation;
  • diarrhea, nausea;
  • collapse;
  • cramps;
  • paralysis;
  • dyspnea;
  • coma.

As indicated in the instructions for use Efoksa an overdose of a drug to a patient is prescribed gastric lavage, and in some cases, infusion is administered dopamine or norepinephrine.It should be noted, the use of epinephrine is strictly prohibited in this situation.Regarding

Efoksa antidotes, then these are drugs such as methylene blue, toluidine blue, and vitamin C in the form of sodium salt.In addition, an overdose Efoksa sufficiently effective procedures such as oxygen therapy, hemodialysis and exchange transfusion.

Analogs Efoksa

At this time in the domestic pharmaceutical market offers such analogs Efoksa on the active substance as a Monosan and Mononitrosid.If necessary, replace the designated Efoksa on analogue patient should get advice from your doctor.


Therapy Efoksa incompatible with alcohol intake.Also during the use of the funds necessary to abandon the patient transport management and complex mechanisms, and avoid performing activities that require increased attention and psychomotor speed reactions.

Experts say that the abrupt withdrawal of the drug is invalid, so the dosage should be reduced gradually.According to the instructions Efoksa, development of manifestations of intolerance is the cause for the absolute rejection of the use of the drug.

Prolonged treatment to Efoksa tolerance develops, but after its cancellation or for some break in the treatment of sensitivity to it restored soon.

Efoksa Shelf life is 5 years from date of manufacture, at a temperature no higher than 25 degrees Celsius.


Product description posted on this page is a supplement and a simplified version of the official version of the annotations to the drug.The information is provided for informational purposes only and is not a guide to self-medication.Before using the product you should consult with a specialist and to get acquainted with the instructions approved by the manufacturer.

Latest Blog Post

Benzyl benzoate - instruction , application reviews
August 12, 2017

Contents: 1. pharmacological action of the drug 2. Indications benzyl 3. Instruction benzyl 4. Contraindications and side eff...

Benga - instruction , application reviews
August 12, 2017

Contents: 1. Pharmacokinetics 2. Guide Bengeya 3. overdose contraindications and 4. Reviews Beng BengIt is a non-stero...

Analgin - instruction , application reviews
August 12, 2017

Contents: 1. Indications Benalgina 2. Instruction Benalginu: method of use and dosage 3. Side effects of the drug 4. Interact...